by John Conrad | Aug 13, 2024 | NewsBrief
In a significant move that reshapes the landscape of the medical technology industry, Baxter International Inc. has announced a definitive agreement to sell its Kidney Care segment, soon to be renamed Vantive, to global investment firm Carlyle for $3.8 billion. This...
